- Home
- PSNL vs AIO Comparison
PSNL vs AIO Comparison
Compare PSNL & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PSNL | AIO |
|---|---|---|
| Founded | 2011 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.1M | 777.8M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | PSNL | AIO |
|---|---|---|
| Price | $8.27 | $22.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $11.33 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 108.2K |
| Earning Date | 03-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.05% |
| EPS Growth | ★ 39.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $84,614,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.87 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.15 | N/A |
| 52 Week Low | $2.83 | $16.18 |
| 52 Week High | $11.50 | $25.47 |
Technical Indicators
Market Signals| Indicator | PSNL | AIO |
|---|---|---|
| Relative Strength Index (RSI) | 44.53 | 52.52 |
| Support Level | $7.28 | $22.41 |
| Resistance Level | $9.70 | $23.08 |
| Average True Range (ATR) | 0.78 | 0.39 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 36.90 | 73.48 |
Price Performance
Historical ComparisonAbout PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest
Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.